Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763139 · ClinicalTrials.gov registry record · NA
Inflammation and Insulin Resistance in Rheumatoid Arthritis
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT00763139 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 34 participants.
The verdict
NCT00763139, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, stiffness, and loss of function in the joints. Over time, joint deformity, joint destruction, and loss of function can occur. Current treatment aims to improve symptoms, but there is no cure for the disease. Pioglitazone is drug that is effective in treating people with diabetes. This study will determine whether pioglitazone can also be used to effectively treat people with RA.
Interventions
- DRUG Placebo
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00763139
The ClinicalTrials.gov registry entry for NCT00763139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00763139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00763139 about?
NCT00763139 is a clinical study titled "Inflammation and Insulin Resistance in Rheumatoid Arthritis". Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, stiffness, and loss of function in the joints. Over time, joint deformity, joint destruction, and loss of function can occur. Current treatment aims to improve symptoms, but there is no cure for the disease. Pioglitazone is...
What is the current status of trial NCT00763139?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2009-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00763139?
The interventions under investigation include: Placebo (DRUG), Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00763139?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.